Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model (2017)
- Authors:
- USP affiliated authors: TEIXEIRA, LISETE RIBEIRO - FM ; FERNEZLIAN, SANDRA DE MORAIS - FM ; CAPELOZZI, VERA LUIZA - FM
- Unidade: FM
- Subjects: ADENOCARCINOMA; DERRAME PLEURAL; NEOPLASIAS PULMONARES
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of thoracic oncology
- ISSN: 1556-0864
- Volume/Número/Paginação/Ano: v. 12, n. 1, suppl.S, p. S1276-S1277, 2017
- Conference titles: World conference on lun cancer - ASLC
-
ABNT
TEIXEIRA, Lisete et al. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 28 dez. 2025. , 2017 -
APA
Teixeira, L., Acencio, M., Alvarenga, V., Silva, G., Brito, Z., Fernezlian, S., et al. (2017). Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S -
NLM
Teixeira L, Acencio M, Alvarenga V, Silva G, Brito Z, Fernezlian S, Puka J, Martins J, Capelozzi V. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2025 dez. 28 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S -
Vancouver
Teixeira L, Acencio M, Alvarenga V, Silva G, Brito Z, Fernezlian S, Puka J, Martins J, Capelozzi V. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2025 dez. 28 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S - Impact of Bacillus Calmette–Guérin Moreau vaccine on lung remodeling in experimental asthma
- Transforming growth factor beta-1 as a predictor of fibrosis in tuberculous pleurisy
- Intrapleural targeted therapies (anti-VEGF and anti-EGFR) in the model of malignant pleural effusion
- Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma
- DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
- A semi-automated microscopic image analysis method for scoring Ki-67 nuclear immunostaining
- Modeling inflammatory mediators and apoptosis pleural mesothelial cells exposed to talc particles
- Sterilized human skin graft with a dose of 25 kGy provides a privileged immune and collagen microenvironment in the adhesion of Nude mice wounds
- Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis
- Distorted lung framework is related to IL-17+ cells immunoexpression in systemic sclerosis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
